Influenza and pneumococcal vaccine coverage rates among patients admitted to a teaching hospital in South Korea

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Influenza and pneumococcal vaccinations can reduce morbidity and mortality especially in the elderly and patients with chronic medical disease. The purpose of this study was to estimate vaccination coverage of these populations in a hospital setting.Materials and Methods: We conducted a cross-sectional, descriptive study involving adult patients admitted to a 1,000-bed teaching hospital on April 15, 2013. We ascertained the information on whether the patient had received influenza vaccination within a year prior to admission or pneumococcal vaccination by interviewing each patient. Results: A total of 491 eligible patients aged ≥50 years or with chronic medical illnesses were analyzed. The overall vaccination rate for influenza was 57.2%, and that of pneumococcus was 17.6% among the vaccine-eligible subjects. Influenza/pneumococcal vaccination rates of patients by disease were 62.8%/17.2% for diabetes, 53.3%/15.6% for malignancy, 67.6%/23.5% for chronic pulmonary disease, 66.7%/15.3% for chronic cardiovascular disease, 68.7%/26.9% for chronic renal disease, and 51.2%/18.6% for chronic hepatic disease. Young adult patients with chronic medical conditions were consistently less likely to receive influenza and pneumococcal vaccines irrespective of the underlying disease. Conclusion: The influenza and pneumococcal vaccine coverage rates among hospitalized patients were low in South Korea.This was especially the case for young adult patients with chronic medical illnesses.

Original languageEnglish
Pages (from-to)41-48
Number of pages8
JournalInfection and Chemotherapy
Volume47
Issue number1
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Pneumococcal Vaccines
Republic of Korea
Influenza Vaccines
Teaching Hospitals
Vaccination
Chronic Disease
Human Influenza
Young Adult
Streptococcus pneumoniae
Chronic Renal Insufficiency
Lung Diseases
Cardiovascular Diseases
Vaccines
Cross-Sectional Studies
Morbidity
Mortality
Liver

Keywords

  • Health survey
  • Hospitalization
  • Influenza
  • Streptococcus pneumoniae
  • Vaccination

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Infectious Diseases

Cite this

@article{f89842ff15e845f1b0686081f97d754c,
title = "Influenza and pneumococcal vaccine coverage rates among patients admitted to a teaching hospital in South Korea",
abstract = "Background: Influenza and pneumococcal vaccinations can reduce morbidity and mortality especially in the elderly and patients with chronic medical disease. The purpose of this study was to estimate vaccination coverage of these populations in a hospital setting.Materials and Methods: We conducted a cross-sectional, descriptive study involving adult patients admitted to a 1,000-bed teaching hospital on April 15, 2013. We ascertained the information on whether the patient had received influenza vaccination within a year prior to admission or pneumococcal vaccination by interviewing each patient. Results: A total of 491 eligible patients aged ≥50 years or with chronic medical illnesses were analyzed. The overall vaccination rate for influenza was 57.2{\%}, and that of pneumococcus was 17.6{\%} among the vaccine-eligible subjects. Influenza/pneumococcal vaccination rates of patients by disease were 62.8{\%}/17.2{\%} for diabetes, 53.3{\%}/15.6{\%} for malignancy, 67.6{\%}/23.5{\%} for chronic pulmonary disease, 66.7{\%}/15.3{\%} for chronic cardiovascular disease, 68.7{\%}/26.9{\%} for chronic renal disease, and 51.2{\%}/18.6{\%} for chronic hepatic disease. Young adult patients with chronic medical conditions were consistently less likely to receive influenza and pneumococcal vaccines irrespective of the underlying disease. Conclusion: The influenza and pneumococcal vaccine coverage rates among hospitalized patients were low in South Korea.This was especially the case for young adult patients with chronic medical illnesses.",
keywords = "Health survey, Hospitalization, Influenza, Streptococcus pneumoniae, Vaccination",
author = "Yang, {Tae Un} and Joon-Young Song and Noh, {Ji Yun} and Hee-Jin Cheong and Kim, {Woo Joo}",
year = "2015",
month = "1",
day = "1",
doi = "10.3947/ic.2015.47.1.41",
language = "English",
volume = "47",
pages = "41--48",
journal = "Infection and Chemotherapy",
issn = "2093-2340",
publisher = "Taehan Kamyom Hakhoe, Taehan Hwahak Yopop Hakhoe",
number = "1",

}

TY - JOUR

T1 - Influenza and pneumococcal vaccine coverage rates among patients admitted to a teaching hospital in South Korea

AU - Yang, Tae Un

AU - Song, Joon-Young

AU - Noh, Ji Yun

AU - Cheong, Hee-Jin

AU - Kim, Woo Joo

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background: Influenza and pneumococcal vaccinations can reduce morbidity and mortality especially in the elderly and patients with chronic medical disease. The purpose of this study was to estimate vaccination coverage of these populations in a hospital setting.Materials and Methods: We conducted a cross-sectional, descriptive study involving adult patients admitted to a 1,000-bed teaching hospital on April 15, 2013. We ascertained the information on whether the patient had received influenza vaccination within a year prior to admission or pneumococcal vaccination by interviewing each patient. Results: A total of 491 eligible patients aged ≥50 years or with chronic medical illnesses were analyzed. The overall vaccination rate for influenza was 57.2%, and that of pneumococcus was 17.6% among the vaccine-eligible subjects. Influenza/pneumococcal vaccination rates of patients by disease were 62.8%/17.2% for diabetes, 53.3%/15.6% for malignancy, 67.6%/23.5% for chronic pulmonary disease, 66.7%/15.3% for chronic cardiovascular disease, 68.7%/26.9% for chronic renal disease, and 51.2%/18.6% for chronic hepatic disease. Young adult patients with chronic medical conditions were consistently less likely to receive influenza and pneumococcal vaccines irrespective of the underlying disease. Conclusion: The influenza and pneumococcal vaccine coverage rates among hospitalized patients were low in South Korea.This was especially the case for young adult patients with chronic medical illnesses.

AB - Background: Influenza and pneumococcal vaccinations can reduce morbidity and mortality especially in the elderly and patients with chronic medical disease. The purpose of this study was to estimate vaccination coverage of these populations in a hospital setting.Materials and Methods: We conducted a cross-sectional, descriptive study involving adult patients admitted to a 1,000-bed teaching hospital on April 15, 2013. We ascertained the information on whether the patient had received influenza vaccination within a year prior to admission or pneumococcal vaccination by interviewing each patient. Results: A total of 491 eligible patients aged ≥50 years or with chronic medical illnesses were analyzed. The overall vaccination rate for influenza was 57.2%, and that of pneumococcus was 17.6% among the vaccine-eligible subjects. Influenza/pneumococcal vaccination rates of patients by disease were 62.8%/17.2% for diabetes, 53.3%/15.6% for malignancy, 67.6%/23.5% for chronic pulmonary disease, 66.7%/15.3% for chronic cardiovascular disease, 68.7%/26.9% for chronic renal disease, and 51.2%/18.6% for chronic hepatic disease. Young adult patients with chronic medical conditions were consistently less likely to receive influenza and pneumococcal vaccines irrespective of the underlying disease. Conclusion: The influenza and pneumococcal vaccine coverage rates among hospitalized patients were low in South Korea.This was especially the case for young adult patients with chronic medical illnesses.

KW - Health survey

KW - Hospitalization

KW - Influenza

KW - Streptococcus pneumoniae

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=84928535046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928535046&partnerID=8YFLogxK

U2 - 10.3947/ic.2015.47.1.41

DO - 10.3947/ic.2015.47.1.41

M3 - Article

VL - 47

SP - 41

EP - 48

JO - Infection and Chemotherapy

JF - Infection and Chemotherapy

SN - 2093-2340

IS - 1

ER -